Auf dieser Seite
VCEL Vericel Corporation - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 30, 2026
$40,15
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$28,9552-Wochen-Tief
$49,3252-Wochen-Hoch
Marktkapitalisierung (MRQ)
$2.05B
P/E (TTM)
83.6
EPS (TTM)
$0.48
Umsatz (TTM)
$306M
Ihre Abzeichen
52W-Spanne
$29–$49
Analystenbewertung
BUY
Kursziel
$61
P/E
83.6
ROE
7.2%
Nettogewinnmarge
7.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VCEL Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$40.15
Marktkapitalisierung (MRQ)
$2.05B
P/E (TTM)
83.6
EPS (TTM)
$0.48
Umsatz (TTM)
$306M
ROE (TTM)
7.2%
52W-Spanne
$29–$49
VCEL Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 16. Oktober 2013 | 1-for-20 | Umgekehrt |
| 18. Februar 2010 | 1-for-8 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$276M2016-12-31 → 2025-12-31
EPS$0.322018-12-31 → 2025-12-31
Freier Cashflow$25M2016-12-31 → 2025-12-31
Nettogewinnmarge7.9%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VCEL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 83.65-Jahres-Durchschnitt ≈-88.5 | ≈-88.5 | · | · | |
| P/S (TTM) | 6.75-Jahres-Durchschnitt ≈9.2 | ≈9.2 | 25.9 | Unterbewertet | |
| K/B (MRQ) | 5.65-Jahres-Durchschnitt ≈7.9 | ≈7.9 | 6.2 | Fairer Wert | |
| Kurs / FCF (TTM) | 33.35-Jahres-Durchschnitt ≈-14.7 | ≈-14.7 | · | · | |
| Kurs / Cashflow (TTM) | 29.55-Jahres-Durchschnitt ≈52.8 | ≈52.8 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 5.65-Jahres-Durchschnitt ≈8.0 | ≈8.0 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈2.1 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VCEL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 74.6%5-Jahres-Durchschnitt ≈70.1% | ≈70.1% | · | · | |
| Betriebsgewinnmarge (TTM) | 6.0%5-Jahres-Durchschnitt ≈-2.6% | ≈-2.6% | -668.2% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 10.2%5-Jahres-Durchschnitt ≈0.08% | ≈0.08% | -668.2% | Spitzenklasse | |
| Pretax Margin (Vorgewinnmarge) | 6.3%5-Jahres-Durchschnitt ≈-1.0% | ≈-1.0% | -765.9% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 7.9%5-Jahres-Durchschnitt ≈-1.2% | ≈-1.2% | -669.0% | Spitzenklasse | |
| ROA (TTM) | 5.2%5-Jahres-Durchschnitt ≈-0.92% | ≈-0.92% | -42.9% | Spitzenklasse | |
| ROE (TTM) | 7.2%5-Jahres-Durchschnitt ≈-1.3% | ≈-1.3% | -80.2% | Spitzenklasse | |
| ROIC | 3.0%5-Jahres-Durchschnitt ≈-2.6% | ≈-2.6% | -119.4% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VCEL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.05-Jahres-Durchschnitt ≈5.0 | ≈5.0 | 6.0 | Unterdurchschnittlich | |
| Quick Ratio (MRQ) | 4.55-Jahres-Durchschnitt ≈4.3 | ≈4.3 | 4.4 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VCEL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 16.4%5-Jahres-Durchschnitt ≈17.5% | ≈17.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 18.9%5-Jahres-Durchschnitt ≈16.9% | ≈16.9% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 17.3% | · | · | · | |
| EPS YoY (EPS VjV) | 60.0% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | 59.4% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 39.8% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 42.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VCEL | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.65-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.1 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 4.05-Jahres-Durchschnitt ≈4.1 | ≈4.1 | 2.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 3.85-Jahres-Durchschnitt ≈4.0 | ≈4.0 | 7.2 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$694.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
53.3%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $0.04 | $-0.03 | 239.4% |
| 31. März 2026 | Mai 13, 2026 | $-0.12 | $-0.16 | 24.1% |
| 31. Dezember 2025 | $0.45 | $0.40 | 13.1% | |
| 30. September 2025 | $0.10 | $-0.01 | — | |
| 30. Juni 2025 | $-0.01 | $-0.03 | 68.7% | |
| 31. März 2025 | $-0.23 | $-0.13 | -78.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $276M | $237M | $198M | $164M | $156M | $124M | $118M | $91M | $64M | $54M | $51M | $29M | |
| Cost of Revenue | $71M | $65M | $62M | $55M | $50M | $40M | $38M | $32M | $30M | $28M | $26M | $17M | |
| Gross Profit | $206M | $172M | $136M | $110M | $106M | $84M | $80M | $59M | $34M | $26M | $25M | $12M | |
| R&D Expense | $28M | $25M | $21M | $20M | $16M | $13M | $30M | $14M | $13M | $15M | $19M | $21M | |
| SG&A Expense | $167M | $143M | $121M | $107M | $98M | $69M | $61M | $49M | $36M | $27M | $22M | $14M | |
| Operating Expenses | $195M | $168M | $142M | $127M | $114M | $82M | $92M | $63M | $49M | $45M | $41M | $35M | |
| Operating Income | $11M | $5M | $-6M | $-17M | $-8M | $2M | $-11M | $-4M | $-15M | $-19M | $-17M | $-24M | |
| Interest Expense | · | · | $600.0K | $366.0K | $4.0K | $6.0K | $8.0K | $31.0K | $92.0K | $15.0K | $9.0K | $6.0K | |
| Interest Income | $7M | $6M | $5M | $1M | $224.0K | $691.0K | $2M | $897.0K | $14.0K | $8.0K | $36.0K | $24.0K | |
| Other Non-op | $-44.0K | $195.0K | $64.0K | $95.0K | $52.0K | $-13.0K | $-20.0K | $-2M | $-1M | $-314.0K | $-20.0K | $-2.0K | |
| Pretax Income | $17M | $11M | $-2M | $-16M | $-8M | $3M | $-10M | $-8M | $-17M | $-20M | $-16M | $-20M | |
| Income Tax | $859.0K | $148.0K | $814.0K | $721.0K | $-111.0K | $180.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $17M | $10M | $-3M | $-17M | $-7M | $3M | $-10M | $-8M | $-17M | $-20M | $-16M | $-20M | |
| EPS (Basic) | $0.33 | $0.21 | $-0.07 | $-0.35 | $-0.16 | $0.06 | $-0.22 | $-0.20 | · | · | · | · | |
| EPS (Diluted) | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 | $0.06 | $-0.22 | $-0.20 | · | · | · | · | |
| Shares (Basic) | 50,340,000 | 48,848,000 | 47,590,000 | 47,130,000 | 46,472,000 | 45,221,000 | 44,180,000 | 40,242,000 | · | · | · | · | |
| Shares (Diluted) | 52,151,000 | 51,679,000 | 47,590,000 | 47,130,000 | 46,472,000 | 47,282,000 | 44,180,000 | 40,242,000 | · | · | · | · | |
| EBITDA | $23M | $10M | $-2M | $-13M | $-5M | $5M | $-10M | $-2M | $-13M | $-17M | $-15M | $-23M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $75M | $69M | $51M | $68M | $34M | $27M | $18M | $27M | $23M | $15M | $30M | |
| Short-term Investments | $37M | $42M | $40M | $68M | $35M | $42M | $43M | $65M | $0 | · | · | · | |
| Receivables | $85M | $61M | $58M | $47M | $37M | $35M | $32M | $23M | $18M | $17M | $11M | $8M | |
| Inventory | $18M | $17M | $13M | $16M | $13M | $9M | $7M | $4M | $4M | $3M | $1M | $2M | |
| Other Current Assets | $8M | $7M | $7M | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $464.0K | $1M | |
| Current Assets | $247M | $213M | $206M | $187M | $158M | $124M | $112M | $113M | $51M | $45M | $27M | $41M | |
| PP&E (Net) | · | · | · | · | · | · | · | $6M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $13M | $11M | $11M | $10M | $7M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $8M | $7M | $7M | $6M | $4M | |
| Intangibles | $6M | $6M | $7M | $8M | $0 | · | · | · | · | $0 | $3M | $3M | |
| Other Non-current Assets | $341.0K | $556.0K | $771.0K | $1M | $317.0K | $0 | · | · | · | · | · | · | |
| Total Assets | $488M | $433M | $354M | $273M | $244M | $206M | $153M | $119M | $55M | $49M | $34M | $48M | |
| Accounts Payable | $16M | $24M | $22M | $17M | $9M | $7M | $6M | $7M | $6M | $7M | $8M | $6M | |
| Accrued Liabilities | $19M | $17M | $17M | $16M | $14M | $11M | $8M | $7M | $6M | $5M | $4M | $5M | |
| Current Liabilities | $49M | $50M | $46M | $37M | $26M | $22M | $20M | $15M | $13M | $13M | $12M | $12M | |
| Capital Leases | $82M | $90M | $82M | $43M | $47M | $49M | $22M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $2M | $876.0K | $100.0K | $0 | $44.0K | $76.0K | $110.0K | $2M | · | $32.0K | · | $0 | |
| Total Liabilities | $133M | $141M | $128M | $81M | $73M | $71M | $42M | $16M | $32M | $24M | $12M | $12M | |
| Common Stock | $731M | $685M | $629M | $593M | $554M | $510M | $490M | $471M | $383M | $330M | $308M | $305M | |
| Retained Earnings | $-376M | $-393M | $-403M | $-400M | $-383M | $-376M | $-379M | $-369M | $-361M | $-344M | $-324M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | $0 | $3M | $0 | |
| AOCI | $275.0K | $4.0K | $-100.0K | $-978.0K | $-154.0K | $14.0K | $21.0K | $-39.0K | $0 | $190.0K | $0 | $-71.0K | |
| Stockholders' Equity | $355M | $292M | $226M | $192M | $170M | $134M | $111M | $102M | $23M | $25M | $22M | $36M | |
| Liabilities + Equity | $488M | $433M | $354M | $273M | $244M | $206M | $153M | $119M | $55M | $49M | $34M | $48M | |
| Shares Outstanding | 50,620,000 | 49,628,000 | 47,829,000 | 47,253,000 | 46,880,000 | 45,804,000 | 44,864,000 | 43,578,000 | 35,861,000 | 31,595,000 | 23,789,000 | 23,786,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $6M | $5M | $4M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $752.0K | |
| Stock-based Comp | $39M | $36M | $32M | $37M | $34M | $14M | $13M | $7M | $3M | $2M | $3M | $839.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $300.0K | $300.0K | $200.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $100.0K | · | $3M | |
| Other Non-cash | $-15M | $6M | $2M | $-7M | $-811.0K | $-2M | $-12M | $-924.0K | $-189.0K | $-5M | $-1M | $-7M | |
| Operating Cash Flow | $52M | $58M | $35M | $18M | $29M | $18M | $-7M | $-412.0K | $-13M | $-20M | $-13M | $-25M | |
| CapEx | $27M | $64M | $20M | $8M | $8M | $3M | $3M | $3M | $2M | $1M | $2M | $829.0K | |
| Investing Cash Flow | $-44M | $-79M | $-3M | $-36M | $-4M | $-17M | $11M | $-67M | $-2M | $-1M | $-2M | · | |
| Stock Issued | $14M | $25M | $6M | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $14M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $7M | $19M | $4M | $1M | $9M | $6M | $5M | $59M | $19M | $30M | $-24.0K | · | |
| Net Change in Cash | $15M | $-2M | $36M | $-17M | $35M | $7M | $9M | $-9M | $4M | · | · | · | |
| Taxes Paid | $580.0K | $628.0K | $1M | $0 | $379.0K | $147.0K | $80.0K | · | · | · | · | · | |
| Free Cash Flow | $25M | $-6M | $15M | $10M | $21M | $15M | $-10M | $-3M | $-15M | $-21M | $-16M | $-26M | |
| Levered FCF | · | · | $14M | $10M | $21M | $15M | $-10M | $-3M | $-16M | $-22M | $-16M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.4% | 72.5% | 68.6% | 66.8% | 67.9% | 67.8% | 68.1% | 64.6% | 52.5% | 47.9% | 48.3% | 40.0% | |
| Operating Margin | 4.0% | 1.9% | -3.3% | -10.4% | -5.0% | 1.9% | -9.6% | -4.3% | -23.4% | -35.4% | -32.6% | -81.7% | |
| Net Margin | 6.0% | 4.4% | -1.6% | -10.2% | -4.8% | 2.3% | -8.2% | -9.0% | -27.0% | -36.0% | -31.9% | -69.2% | |
| Pretax Margin | 6.3% | 4.4% | -1.2% | -9.7% | -4.9% | 2.5% | -8.2% | -9.0% | -27.0% | -36.0% | -31.9% | -69.2% | |
| EBITDA Margin | 8.2% | 4.2% | -0.93% | -8.0% | -3.1% | 3.8% | -8.1% | -2.7% | -20.9% | -31.9% | -29.5% | -79.1% | |
| ROA | 3.6% | 2.6% | -1.0% | -6.5% | -3.3% | 1.6% | -7.1% | -9.4% | -33.5% | -47.2% | -39.9% | -70.2% | |
| ROE | 5.0% | 3.8% | -1.5% | -9.0% | -4.6% | 2.3% | -9.3% | -8.3% | -73.2% | -83.5% | -56.6% | -100.8% | |
| ROIC | 3.0% | 1.5% | -3.8% | -9.3% | -4.5% | 1.7% | -10.1% | -3.8% | -66.5% | -77.9% | -75.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.2 | 4.5 | 5.0 | 6.1 | 5.5 | 5.6 | 7.6 | 3.9 | 3.5 | 2.3 | 3.5 | |
| Quick Ratio | 4.5 | 3.5 | 3.7 | 4.4 | 5.4 | 4.9 | 5.1 | 7.2 | 3.4 | 3.1 | 2.1 | 3.3 | |
| Interest Coverage | · | · | -10.8 | -46.6 | -1963.5 | 182.5 | -562.5 | -126.1 | -13.5 | -61.3 | -1852.3 | -3922.3 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.9 | 1.0 | 1.2 | 1.3 | 1.2 | 1.0 | |
| Inventory Turnover | 4.0 | 4.3 | 4.3 | 3.7 | 4.4 | 4.9 | 7.2 | 8.7 | 8.3 | 11.6 | 16.0 | 18.0 | |
| Receivables Turnover | 3.8 | 4.0 | 3.8 | 3.9 | 4.3 | 3.7 | 4.2 | 4.4 | 3.6 | 3.9 | 5.4 | 7.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.01 | $5.88 | $4.72 | $4.07 | $3.64 | $2.93 | $2.48 | $2.35 | $0.63 | $0.78 | $0.93 | $1.50 | |
| Revenue / Share | $5.30 | $4.59 | $4.15 | $3.49 | $3.36 | $2.63 | · | · | · | · | · | · | |
| Cash Flow / Share | $1.00 | $1.13 | $0.74 | $0.38 | $0.62 | $0.37 | · | · | · | · | · | · | |
| Cash / Share | $1.98 | $1.50 | $1.44 | $1.08 | $1.46 | $0.73 | $0.60 | $0.42 | $0.75 | $0.73 | $0.61 | $1.28 | |
| EPS (TTM) | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 | $0.06 | $-0.22 | $-0.20 | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.4% | 20.1% | 20.2% | 5.2% | 25.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.9% | 14.9% | 16.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 39.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 59.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 42.0% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $276M | $237M | $198M | $164M | $156M | $124M | $118M | $91M | $64M | $54M | $51M | $29M | |
| Net Income TTM | $17M | $10M | $-3M | $-17M | $-7M | $3M | $-10M | $-8M | $-17M | $-20M | $-16M | $-20M | |
| Market Cap | $1.82B | $2.73B | $1.70B | $1.24B | $1.84B | $1.41B | $781M | $758M | $195M | $95M | $61M | $72M | |
| P/E | 112.5 | 274.6 | -508.7 | -75.3 | -245.6 | 514.7 | -79.1 | -87.0 | · | · | · | · | |
| P/S | 6.6 | 11.5 | 8.6 | 7.6 | 11.8 | 11.4 | 6.6 | 8.3 | 3.1 | 1.7 | 1.2 | 2.5 | |
| P/B | 5.1 | 9.3 | 7.5 | 6.5 | 10.8 | 10.5 | 7.0 | 7.4 | 8.7 | 3.8 | 2.8 | 2.0 | |
| P / Tangible Book | 5.2 | 9.5 | 7.8 | 6.7 | 10.8 | 10.5 | · | · | · | · | · | · | |
| P / Cash Flow | 35.1 | 46.9 | 48.2 | 70.4 | 63.4 | 80.5 | -108.7 | -1840.4 | -14.8 | -4.8 | -4.6 | -2.8 | |
| P / FCF | 73.7 | -469.0 | 111.3 | 123.3 | 87.2 | 94.6 | -79.7 | -245.4 | -13.3 | -4.4 | -3.9 | -2.8 | |
| Earnings Yield | 0.89% | 0.36% | -0.20% | -1.3% | -0.41% | 0.19% | -1.3% | -1.1% | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77M | $68M | $93M | $68M | $63M | $53M | $75M | $58M | $53M | $51M | $65M | $46M | $46M | $41M | $53M | $39M | |
| Cost of Revenue | $21M | $19M | $20M | $18M | $17M | $16M | $17M | $16M | $16M | $16M | $16M | $15M | $16M | $14M | $14M | $13M | |
| Gross Profit | $56M | $49M | $73M | $50M | $47M | $36M | $58M | $42M | $37M | $35M | $49M | $31M | $30M | $27M | $38M | $25M | |
| R&D Expense | $7M | $8M | $7M | $6M | $7M | $7M | $5M | $6M | $7M | $6M | $5M | $6M | $5M | $5M | $5M | $5M | |
| SG&A Expense | $48M | $49M | $43M | $40M | $42M | $42M | $35M | $38M | $35M | $34M | $31M | $30M | $31M | $29M | $27M | $27M | |
| Operating Expenses | $56M | $57M | $51M | $46M | $49M | $49M | $40M | $44M | $43M | $41M | $36M | $36M | $36M | $35M | $32M | $32M | |
| Operating Income | $434.0K | $-8M | $22M | $3M | $-2M | $-13M | $18M | $-2M | $-6M | $-5M | $13M | $-5M | $-6M | $-8M | $6M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $153.0K | · | $150.0K | $149.0K | $145.0K | · | $105.0K | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $839.0K | $763.0K | $342.0K | |
| Other Non-op | $-22.0K | $71.0K | $-36.0K | $-26.0K | $-24.0K | $42.0K | $70.0K | $140.0K | $-8.0K | $-7.0K | $-2M | $-1.0K | $941.0K | $682.0K | $-3.0K | $-5.0K | |
| Pretax Income | · | · | · | · | · | · | $20M | $-901.0K | · | · | $14M | $-4M | · | · | $7M | $-7M | |
| Income Tax | · | · | · | · | · | · | $148.0K | $0 | · | · | $1M | $-286.0K | · | · | $700.0K | $21.0K | |
| Net Income | $2M | $-6M | $23M | $5M | $-553.0K | $-11M | $20M | $-901.0K | $-5M | $-4M | $13M | $-4M | $-5M | $-7M | $6M | $-7M | |
| EPS (Basic) | $0.04 | $-0.12 | $0.47 | $0.10 | $-0.01 | $-0.23 | $0.41 | $-0.02 | $-0.10 | $-0.08 | $0.28 | $-0.08 | $-0.11 | $-0.16 | $0.13 | $-0.14 | |
| EPS (Diluted) | $0.04 | $-0.12 | $0.46 | $0.10 | $-0.01 | $-0.23 | $0.40 | $-0.02 | $-0.10 | $-0.08 | $0.28 | $-0.08 | $-0.11 | $-0.16 | $0.13 | $-0.14 | |
| Shares (Basic) | 51,075,000 | 50,773,000 | · | 50,489,000 | 50,368,000 | 49,905,000 | · | 49,085,000 | 48,686,000 | 48,141,000 | · | 47,649,000 | 47,572,000 | 47,387,000 | · | 47,182,000 | |
| Shares (Diluted) | 52,312,000 | 50,773,000 | · | 51,908,000 | 50,368,000 | 49,905,000 | · | 49,085,000 | 48,686,000 | 48,141,000 | · | 47,649,000 | 47,572,000 | 47,387,000 | · | 47,182,000 | |
| EBITDA | $434.0K | $-5M | · | $3M | $-2M | $-10M | · | $-2M | $-6M | $-4M | · | $-5M | $-6M | $-7M | · | $-6M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $109M | $100M | $100M | $81M | $73M | $75M | $54M | $50M | $63M | $69M | $60M | $43M | $62M | $51M | $65M | |
| Short-term Investments | $37M | $36M | $37M | $35M | $36M | $39M | $42M | $48M | $52M | $48M | · | $45M | $55M | $57M | · | $46M | |
| Receivables | $76M | $72M | $85M | $60M | $64M | $53M | $61M | $48M | $48M | $50M | · | $40M | $38M | $38M | · | $34M | |
| Inventory | $18M | $18M | $18M | $18M | $17M | $17M | $17M | $16M | $15M | $14M | · | $13M | $14M | $15M | · | $17M | |
| Other Current Assets | $8M | $8M | $8M | $8M | $7M | $9M | $7M | $8M | $6M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Assets | $265M | $244M | $247M | $222M | $205M | $198M | $213M | $191M | $197M | $190M | · | $186M | $183M | $178M | · | $166M | |
| Intangibles | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | · | $7M | $7M | $7M | · | · | |
| Other Non-current Assets | $233.0K | $288.0K | $341.0K | $395.0K | $447.0K | $501.0K | $556.0K | $610.0K | $664.0K | $717.0K | · | $1M | $1M | $1M | · | $1M | |
| Total Assets | $503M | $486M | $488M | $453M | $436M | $425M | $433M | $390M | $377M | $357M | · | $318M | $311M | $265M | · | $248M | |
| Accounts Payable | $21M | $19M | $16M | $15M | $13M | $17M | $24M | $21M | $25M | $19M | · | $15M | $14M | $11M | · | $8M | |
| Accrued Liabilities | $18M | $14M | $19M | $16M | $14M | $11M | $17M | $14M | $13M | $11M | · | $14M | $14M | $13M | · | $14M | |
| Current Liabilities | $53M | $47M | $49M | $46M | $41M | $39M | $50M | $41M | $44M | $36M | · | $36M | $36M | $29M | · | $27M | |
| Capital Leases | $78M | $80M | $82M | $84M | $86M | $88M | $90M | $91M | $90M | $86M | · | $78M | $76M | $42M | · | $43M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $876.0K | $243.0K | $198.0K | $154.0K | · | $65.0K | $28.0K | · | · | $0 | |
| Total Liabilities | $133M | $129M | $133M | $131M | $129M | $129M | $141M | $133M | $134M | $123M | · | $114M | $112M | $71M | · | $70M | |
| Common Stock | $751M | $739M | $731M | $721M | $711M | $699M | $685M | $670M | $655M | $641M | · | $621M | $612M | $602M | · | $585M | |
| Retained Earnings | $-380M | $-383M | $-376M | $-400M | $-405M | $-404M | $-393M | $-413M | $-412M | $-407M | · | $-416M | $-413M | $-407M | · | $-406M | |
| AOCI | $-365.0K | $-168.0K | $275.0K | $258.0K | $183.0K | $136.0K | $4.0K | $359.0K | $-273.0K | $-245.0K | · | $-463.0K | $-621.0K | $-636.0K | · | $-1M | |
| Stockholders' Equity | $370M | $356M | $355M | $322M | $307M | $295M | $292M | $257M | $243M | $234M | $226M | $204M | $199M | $194M | $192M | $178M | |
| Liabilities + Equity | $503M | $486M | $488M | $453M | $436M | $425M | $433M | $390M | $377M | $357M | · | $318M | $311M | $265M | · | $248M | |
| Shares Outstanding | 51,171,000 | 51,010,000 | 50,620,000 | 50,550,000 | 50,441,000 | 50,252,000 | 49,628,000 | 49,265,000 | 48,862,000 | 48,489,000 | 47,829,000 | 47,684,000 | 47,616,000 | 47,507,000 | 47,253,000 | 47,201,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $3M | $3M | $3M | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $9M | $11M | $8M | $9M | $10M | $12M | $8M | $9M | $10M | $10M | $7M | $8M | $9M | $9M | $8M | $9M | |
| Other Non-cash | · | $8M | · | · | · | $4M | · | · | · | $-148.0K | · | · | · | $5M | · | · | |
| Operating Cash Flow | $16M | $16M | $15M | $22M | $8M | $7M | $22M | $10M | $19M | $7M | $10M | $7M | $10M | $8M | $7M | $4M | |
| CapEx | $2M | $1M | $2M | $3M | $8M | $14M | $14M | $19M | $17M | $14M | $8M | $7M | $4M | $1M | $1M | $1M | |
| Investing Cash Flow | $-3M | $-4M | $-16M | $-3M | $-9M | $-15M | $-15M | $-21M | $-18M | $-25M | $-8M | $5M | $-2M | $3M | $-22M | $-811.0K | |
| Stock Issued | $3M | $2M | $1M | $1M | $2M | $9M | $7M | $6M | $4M | $7M | $1M | $1M | $1M | $2M | · | $829.0K | |
| Net Stock Activity | · | $2M | · | · | · | $9M | · | · | · | $7M | · | · | · | $2M | · | · | |
| Financing Cash Flow | $3M | $-3M | $1M | $1M | $2M | $3M | $7M | $6M | $4M | $2M | $1M | $1M | $1M | $107.0K | $605.0K | $-312.0K | |
| Net Change in Cash | $16M | $9M | $-311.0K | $20M | $827.0K | $-5M | $15M | $-6M | $5M | $-16M | $3M | $13M | $9M | $11M | $-14M | $3M | |
| Free Cash Flow | · | $15M | · | · | · | $-8M | · | · | · | $-7M | · | · | · | $6M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.8% | 72.0% | · | 73.5% | 73.7% | 69.0% | · | 71.9% | 69.5% | 68.9% | · | 67.2% | 65.2% | 64.7% | · | 65.5% | |
| Operating Margin | 0.56% | -11.8% | · | 5.1% | -3.2% | -24.3% | · | -4.3% | -11.5% | -10.7% | · | -11.1% | -13.0% | -19.9% | · | -17.6% | |
| Net Margin | 2.9% | -9.2% | · | 7.5% | -0.87% | -21.4% | · | -1.6% | -8.9% | -7.5% | · | -8.0% | -10.9% | -18.3% | · | -17.1% | |
| Pretax Margin | · | · | · | · | · | · | · | -1.6% | · | · | · | -8.7% | · | · | · | -17.0% | |
| EBITDA Margin | 0.56% | -7.0% | · | 5.1% | -3.2% | -19.2% | · | -4.3% | -11.5% | -8.0% | · | -11.1% | -13.0% | -17.1% | · | -15.0% | |
| ROA | 0.47% | -1.4% | · | 1.2% | -0.14% | -2.9% | · | -0.25% | -1.4% | -1.2% | · | -1.3% | -1.8% | -3.0% | · | -2.8% | |
| ROE | 0.65% | -1.9% | · | 1.8% | -0.20% | -4.2% | · | -0.39% | -2.1% | -1.8% | · | -1.9% | -2.7% | -4.1% | · | -3.9% | |
| ROIC | · | · | · | · | · | · | · | -0.96% | · | · | · | -2.3% | · | · | · | -3.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.2 | · | 4.9 | 5.0 | 5.0 | · | 4.6 | 4.5 | 5.2 | · | 5.2 | 5.1 | 6.2 | · | 6.2 | |
| Quick Ratio | 4.5 | 4.6 | · | 4.3 | 4.4 | 4.2 | · | 3.6 | 3.4 | 4.4 | · | 4.0 | 3.8 | 5.5 | · | 5.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.7 | · | -33.7 | -40.0 | -56.4 | · | -64.6 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 0.9 | |
| Receivables Turnover | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.2 | · | 1.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.23 | $6.98 | · | $6.37 | $6.08 | $5.88 | · | $5.23 | $4.97 | $4.82 | · | $4.29 | $4.18 | $4.08 | · | $3.77 | |
| Revenue / Share | $1.48 | $1.35 | · | $1.30 | $1.26 | $1.05 | · | $1.18 | $1.08 | $1.07 | · | $0.96 | $0.97 | $0.87 | · | $0.82 | |
| Cash Flow / Share | · | $0.32 | · | · | · | $0.13 | · | · | · | $0.15 | · | · | · | $0.17 | · | · | |
| Cash / Share | $2.45 | $2.14 | · | $1.99 | $1.60 | $1.46 | · | $1.09 | $1.03 | $1.30 | · | $1.27 | $0.90 | $1.30 | · | $1.38 | |
| EPS (TTM) | $0.48 | $0.43 | · | $0.26 | $0.14 | $0.05 | · | $0.08 | $0.02 | $0.01 | · | $-0.22 | $-0.28 | $-0.36 | · | $-0.38 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $306M | $292M | · | $259M | $249M | $239M | · | $227M | $215M | $208M | · | $185M | $178M | $169M | · | $159M | |
| Net Income TTM | $24M | $21M | · | $13M | $7M | $3M | · | $4M | $789.0K | $451.0K | · | $-10M | $-13M | $-17M | · | $-18M | |
| Market Cap | $2.28B | $1.64B | · | $1.59B | $2.15B | $2.24B | · | $2.08B | $2.24B | $2.52B | · | $1.60B | $1.79B | $1.39B | · | $1.10B | |
| P/E | 92.7 | 74.8 | · | 121.0 | 303.9 | 892.4 | · | 528.1 | 2294.0 | 5202.0 | · | -152.4 | -134.2 | -81.4 | · | -61.1 | |
| P/S | 7.4 | 5.6 | · | 6.1 | 8.6 | 9.4 | · | 9.2 | 10.5 | 12.1 | · | 8.6 | 10.0 | 8.2 | · | 6.9 | |
| P/B | 6.2 | 4.6 | · | 4.9 | 7.0 | 7.6 | · | 8.1 | 9.2 | 10.8 | · | 7.8 | 9.0 | 7.2 | · | 6.2 | |
| P / Tangible Book | 6.2 | 4.7 | · | 5.0 | 7.1 | 7.7 | · | 8.3 | 9.5 | 11.1 | · | 8.1 | 9.3 | 7.5 | · | 6.2 | |
| P / Cash Flow | · | 100.2 | · | · | · | 339.7 | · | · | · | 350.2 | · | · | · | 177.2 | · | · | |
| Earnings Yield | 1.1% | 1.3% | · | 0.83% | 0.33% | 0.11% | · | 0.19% | 0.04% | 0.02% | · | -0.66% | -0.75% | -1.2% | · | -1.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $276M | $237M | $198M | $164M | $156M |
| Bruttogewinnmarge % | 74.4% | 72.5% | 68.6% | 66.8% | 67.9% |
| Betriebsgewinnmarge % | 4.0% | 1.9% | -3.3% | -10.4% | -5.0% |
| Nettoergebnis | $17M | $10M | $-3M | $-17M | $-7M |
| Verwässerte EPS | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.0 | 4.2 | 4.5 | 5.0 | 6.1 |
| Quick Ratio | 4.5 | 3.5 | 3.7 | 4.4 | 5.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $25M | $-6M | $15M | $10M | $21M |
Institutionelle Eigentümer (13F) 334 Einreicher · $2.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
334
Gehaltener Wert
$2.5B
Neue Positionen
65
Geschlossene Positionen
22
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 65 (+19 vs. Vorquartal) | 22 (-6 vs. Vorquartal) | 119 (+19 vs. Vorquartal) | 96 (+1 vs. Vorquartal) | -2.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $360.023.135 | 8.092.226 | 14,42% | Aktien |
| STATE STREET CORP | $146.576.910 | 3.293.975 | 5,87% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $129.745.965 | 2.916.295 | 5,20% | Aktien |
| VANGUARD GROUP INC | $129.060.056 | 3.584.006 | 5,17% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $100.357.339 | 2.255.728 | 4,02% | Aktien |
| Conestoga Capital Advisors, LLC | $92.709.686 | 2.083.832 | 3,71% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $88.662.119 | 1.992.855 | 3,55% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $72.963.066 | 1.639.988 | 2,92% | Aktien |
| Soleus Capital Management, L.P. | $64.917.672 | 1.459.152 | 2,60% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $59.683.458 | 1.341.244 | 2,39% | Aktien |
| GENEVA CAPITAL MANAGEMENT LLC | $59.577.597 | 1.339.123 | 2,39% | Aktien |
| LOOMIS SAYLES & CO L P | $53.398.633 | 1.200.239 | 2,14% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $47.192.901 | 1.060.753 | 1,89% | Aktien |
| BANK OF AMERICA CORP /DE/ | $45.210.026 | 1.016.184 | 1,81% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $40.318.991 | 906.200 | 1,61% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $39.892.003 | 896.651 | 1,60% | Aktien |
| ROYAL BANK OF CANADA | $34.514.000 | 775.762 | 1,38% | Aktien |
| Champlain Investment Partners, LLC | $33.626.788 | 755.828 | 1,35% | Aktien |
| Aberdeen Group plc | $31.598.489 | 710.238 | 1,27% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $29.555.000 | 664.305 | 1,18% | Aktien |
| NEXT CENTURY GROWTH INVESTORS LLC | $27.253.862 | 612.584 | 1,09% | Aktien |
| NORTHERN TRUST CORP | $26.589.047 | 597.641 | 1,06% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $25.847.889 | 580.982 | 1,04% | Aktien |
| SG Capital Management LLC | $25.415.001 | 571.252 | 1,02% | Aktien |
| Nuveen, LLC | $23.388.571 | 525.704 | 0,94% | Aktien |
| GOLDMAN SACHS GROUP INC | $23.384.834 | 525.620 | 0,94% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $22.601.498 | 508.013 | 0,91% | Aktien |
| BROWN CAPITAL MANAGEMENT LLC | $22.425.140 | 504.049 | 0,90% | Aktien |
| D. E. Shaw & Co., Inc. | $20.122.338 | 452.289 | 0,81% | Aktien |
| Point72 Asset Management, L.P. | $19.724.019 | 443.336 | 0,79% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $19.718.323 | 443.208 | 0,79% | Aktien |
| SEI INVESTMENTS CO | $19.575.154 | 439.990 | 0,78% | Aktien |
| TimesSquare Capital Management, LLC | $18.604.973 | 578.333 | 0,75% | Aktien |
| MORGAN STANLEY | $17.976.724 | 404.062 | 0,72% | Aktien |
| OSTERWEIS CAPITAL MANAGEMENT INC | $17.723.259 | 398.365 | 0,71% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $16.262.385 | 365.529 | 0,65% | Aktien |
| UBS Group AG | $15.683.927 | 352.527 | 0,63% | Aktien |
| Balyasny Asset Management L.P. | $15.382.818 | 345.759 | 0,62% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $14.696.044 | 330.322 | 0,59% | Aktien |
| Invesco Ltd. | $13.755.507 | 309.182 | 0,55% | Aktien |
| JPMORGAN CHASE & CO | $13.527.202 | 297.759 | 0,54% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $12.605.256 | 283.328 | 0,50% | Aktien |
| Bank of New York Mellon Corp | $12.366.330 | 277.958 | 0,50% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $12.230.998 | 274.916 | 0,49% | Aktien |
| Woodline Partners LP | $12.090.291 | 271.753 | 0,48% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $11.107.952 | 249.673 | 0,44% | Aktien |
| JANE STREET GROUP, LLC | $11.041.216 | 248.173 | 0,44% | Aktien |
| FEDERATED HERMES, INC. | $10.304.551 | 231.615 | 0,41% | Aktien |
| AMERIPRISE FINANCIAL INC | $8.806.261 | 197.938 | 0,35% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8.254.185 | 185.529 | 0,33% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter | 2. März 2005 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 7. September 2004 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 39 Insider · 16 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dominick Colangelo | President and CEO | 24. Februar 2026 M | 312.446 | 0 | 0 | $0 |
| Timothy M Mayleben | President and CEO | 29. August 2012 A | 133.000 | 0 | 0 | $0 |
| Joseph Anthony Mara Jr | Chief Financial Officer | 26. Juni 2026 S | 16.009 | 0 | 2 | $-426.250 |
| Gerard J Michel | CFO and VP, Corp. Development | 1. April 2020 M | 253.865 | 0 | 0 | $0 |
| Scott Durbin | CFO | 4. Januar 2012 S | 0 | 0 | 0 | $0 |
| Gerald Brennan JR | VP Admin. and Finance, CFO | 30. November 2007 A | 30.000 | 0 | 0 | $0 |
| Alan M Wright | SVP, CFO | 12. August 2004 A | 50.000 | 0 | 0 | $0 |
| Daniel Orlando | Chief Operating Officer | 6. Februar 2019 A | 58.191 | 0 | 0 | $0 |
| Jonathan Siegal | Principal Accounting Officer | 30. Juli 2026 M | 1.078 | 0 | 7 | $-530.762 |
| Sean C. Flynn | Chief Legal Officer | 26. Juni 2026 M | 1.647 | 0 | 4 | $-2.041.280 |
| Jonathan Mark Hopper | Chief Medical Officer | 26. Juni 2026 M | 75.753 | 0 | 5 | $-789.304 |
| Karen Mahoney | Chief Human Resources Officer | 22. Juli 2025 M | 1.854 | 0 | 0 | $0 |
| Michael W. Elliston | Controller | 3. Januar 2014 A | · | 0 | 0 | $0 |
| Sharon Watling | VP Clinical Development | 25. Juni 2012 A | · | 0 | 0 | $0 |
| Ronnda Bartel | Chief Scientific Officer | 25. Juni 2012 A | · | 0 | 0 | $0 |
| Brian Gibson | Vice President | 3. Mai 2012 A | · | 0 | 0 | $0 |
| Paul K Wotton | Direktor | 11. Mai 2026 S | 18.802 | 0 | 4 | $-516.925 |
| Lisa Wright | Direktor | 29. April 2026 A | 15.851 | 0 | 0 | $0 |
| Heidi Hagen | Direktor | 29. April 2026 A | 35.050 | 0 | 1 | $-486.150 |
| Alan L Rubino | Direktor | 29. April 2026 A | 64.194 | 0 | 0 | $0 |
| Robert L Zerbe MD | Direktor | 29. April 2026 A | 32.995 | 0 | 0 | $0 |
| Steven C Gilman | Direktor | 16. Oktober 2024 M | 11.000 | 0 | 0 | $0 |
| Nelson M Simms | Direktor | 20. März 2015 A | 225.000 | 0 | 0 | $0 |
| Ronald M Cresswell | Direktor | 2. Mai 2013 A | 40.000 | 0 | 0 | $0 |
| Harold C Urschel Jr | Direktor | 23. Oktober 2012 A | · | 0 | 0 | $0 |
| George W Dunbar JR | Direktor | 11. März 2010 A | 12.750 | 0 | 0 | $0 |
| Susan Wyant | Direktor | 7. November 2007 A | 6.900 | 0 | 0 | $0 |
| Douglas R Armstrong PHD | Direktor | 17. Juli 2006 A | 577.063 | 0 | 0 | $0 |
| Kevin F Mclaughlin | · | 12. August 2026 M | 18.300 | 0 | 5 | $-1.054.235 |
| Michael Halpin | · | 3. August 2026 M | 16.394 | 0 | 6 | $-2.043.907 |
| SUDOVAR STEPHEN | · | 17. Oktober 2008 A | 26.900 | 0 | 0 | $0 |
| Robert Bard | · | 7. September 2006 A | 20.100 | 0 | 0 | $0 |
| Brian Hampson | · | 7. September 2006 A | 42.673 | 0 | 0 | $0 |
| Janet Mary Hock | · | 12. Mai 2006 M | 37.136 | 0 | 0 | $0 |
| Linda M Fingerle | · | 20. Dezember 2005 S | 6.927 | 0 | 0 | $0 |
| James Andrew Cour | · | 20. September 2005 A | 45.000 | 0 | 0 | $0 |
| Arthur Staubitz | · | 20. Dezember 2004 A | · | 0 | 0 | $0 |
| Joseph A Taylor | · | 10. November 2004 A | · | 0 | 0 | $0 |
| Mary L Campbell | · | 21. Juli 2004 P | 1.633 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 45 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 2,57% | 271.504 SH | 1. Oktober 2026 | Täglich |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,11% | 49.341 SH | 1. Oktober 2026 | Täglich |
| JSMD · Janus Detroit Street Trust | 1,03% | 236.414 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,96% | 75.417 NS | 31. Juli 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,63% | 4.120 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,41% | 116.113 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,38% | 40.581 NS | 31. Juli 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,25% | 60.786 SH | 19. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,22% | 6.148 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,14% | 386.903 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,14% | 55.283 SH | 19. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 7.887 SH | 1. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3.620 SH | 1. Oktober 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,13% | 39.214 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,13% | 483.174 SH | 11. September 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 178.611 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,11% | 554 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 13.906 NS | 31. Juli 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 10.519 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,08% | 24.683 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 296.573 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,06% | 16.205 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,06% | 1.313.242 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 3.112 SH | 1. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,05% | 154.432 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 24.418 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 585.506 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 20.190 SH | 1. Oktober 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 152.527 SH | 19. August 2026 | Täglich |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,02% | 9.950 SH | 1. Oktober 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 3.227 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 87.592 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 3.967 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.282 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.999 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 1.620 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 15.414 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14.707 SH | 9. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 66.394 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.617.776 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.108 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 3.113.982 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 482.327 SH | 9. September 2026 | Täglich |
| XJR · iShares Trust | · | 7.051 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.325 SH | 11. September 2026 | Täglich |
VCEL Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$59.00
+46,9%
5 35,7%
Starker Kauf
7 50,0%
Kauf
2 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-09-28Mittelwert-Ziel $60.57 +50,9%
← Unter allen Zielen
Aktueller Preis $40.15
Tief$55.00
Mittelwert$60.57
Hoch$72.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| VERA | · | -10.9 | · | · | -55.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 30, 2026